A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study-Reference-Cited by-同舟云学术

A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study

Published:2021-10 Issue: Volume:1183 Page:122954
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Hu Xinhua,Xu Yichao,Chen Jinliang,Shen Yuting,Yang Dandan,Hu Yin,Jiang Bo,Lou Honggang,Ruan Zourong

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference26 articles.

1. Pulmonary embolism thrombolysis: a clarion call for international collaboration;Goldhaber;J. Am. Coll. Cardiol.,1992

2. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events;Mekaj;Ther. Clin. Risk Manag.,2015

3. Discovery of anticoagulant drugs: a historical perspective;Gómez-Outes;Curr. Drug Discov. Technol.,2012

4. Stroke prevention in atrial fibrillation: Past, present and future;Lip;Comparing the guidelines and practical decision-making, Thrombosis and haemostasis,2017

5. Beyond heparin and warfarin: the new generation of anticoagulants;Weitz;Expert Opin. Invest. Drugs,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, pharmacokinetics and exploratory exposure-response analysis of CX3002, a novel inhibitor of Xa, in Chinese healthy subjects;European Journal of Pharmaceutical Sciences;2023-06

2. Enhancing antimicrobial activity of β-lactam antibiotic via functionalized mesoporous carbon-based delivery platforms;Microporous and Mesoporous Materials;2022-09